home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Seeing Cathepsin

  August, 24 2005 9:00
your information resource in human molecular genetics
Cathepsins are cysteine proteases involved in a number of stages of tumor development. In the September issue of Nature Chemical Biology, cathepsin activity is visualized in a cellular model of a tumor microenvironment. As a cellular safeguard, proteases are often generated in an inactive form and then processed to the active form only when the protein cutting activity is needed. Although there are many ways for detecting proteases, small molecules called "activity-based probes" that only react with active enzymes offer an important method for monitoring active proteases. Until now, using these probes for in vivo imaging has been difficult.

Matthew Bogyo and colleagues report a new method of fluorescence labeling of active proteases using activity-based probes. The authors chemically synthesized a molecule in which the fluorescence generated by one part of the molecule is "quenched"--or turned off--by another part of the molecule. When the probe reacts with an active protease, the quenching part of the molecule breaks off and a fluorescent signal can be seen. These probes were effective in imaging cathepsin in living cells.

The probes may prove useful for monitoring cathepsin activity in live mice, and the design of similar quenched probes targeting other proteases will provide important tools for investigating proteolytic function in vivo.

Author contact:

Matthew Bogyo (Stanford University, Stanford, CA, USA)
E-mail: mbogyo@stanford.edu

Abstract available online.

(C) Nature Chemical Biology.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.